Intravenous (IV)

IV administration of Remodulin

IV Remodulin is delivered directly into a vein through a narrow, flexible tube called a catheter. To start therapy, your doctor will place the catheter into a vein in your upper chest. The procedure generally takes an hour and a half and may require an overnight stay in the hospital. Once in place, the catheter is attached to an external pump that delivers your medication continuously.

IV Remodulin is administered via a pump option called the CADD-Legacy® 1 pump. CADD-Legacy 1 has been used to deliver many different kinds of drugs for more than a decade.

IV administration features:

  • Medication needs to be mixed with a diluent
  • Pump reservoir is usually refilled every 2 days
  • No infusion site pain typically seen
  • A Specialty Pharmacy nurse can help train you on how to use IV Remodulin and your pump
Learn More
IV Remodulin administered using CADD-Legacy 1

With the IV Remodulin premix program, SPmix, you can save time and avoid mixing errors

Remodulin for IV administration must be mixed and prepared before use. Eligible patients can have 7 days’ worth* of premixed Remodulin shipped directly to their home.

Ask your doctor about how to get started with the SPmix Program.

The SPmix Program is for patients who are taking a consistent dose of Remodulin for at least a month and have been self-mixing for at least 3 months. Based on your doctor’s recommendation, this program may be right for you.

*The amount of premixed Remodulin you receive will depend on the Specialty Pharmacy you choose.

Premix at home

You can also premix IV Remodulin at home. Reservoirs for IV Remodulin can be premixed up to 14 days in advance.

When premixing for storing, Remodulin should be mixed with a sterile high-pH glycine diluent. Remodulin cannot be stored for 14 days when mixed with Sterile Water for Injection or Sodium Chloride Injection (only 4 hours at room temperature or 24 hours refrigerated). To confirm that you are using a sterile high-pH glycine diluent or to discuss switching to one, contact your healthcare provider or Specialty Pharmacy for more information.

If you have questions, talk with your healthcare provider or Specialty Pharmacy.

Stability was demonstrated as low as 0.004 mg/mL.

Remodulin® (treprostinil) Injection

Important Safety Information for Remodulin

Before you take Remodulin, tell your healthcare provider if you:

What are the serious side effects of Remodulin?

What are the possible side effects of Remodulin?

You may report side effects to the FDA at www.fda.gov/MedWatch or call 1-800-FDA-1088.

The risk information provided here is not comprehensive.

What is Remodulin?

Remodulin is a prescription medication used to treat adults with pulmonary arterial hypertension (PAH; WHO Group 1), which is high blood pressure in the arteries of your lungs. Remodulin can reduce symptoms associated with exercise. Remodulin was studied mainly in patients with NYHA Functional Class II-IV symptoms. It is not known if Remodulin is safe and effective in children.

In people with PAH who need to switch from epoprostenol, Remodulin is approved to slow the worsening of symptoms.

REMISIconOct19

To learn more about Remodulin, talk with your healthcare provider. Please see Full Prescribing Information at www.remodulin.com or call Customer Service at 1-877-UNITHER (1-877-864-8437).

PAH=pulmonary arterial hypertension; WHO=World Health Organization.

Remodulin® (treprostinil) Injection

Important Safety Information for Remodulin

Before you take Remodulin, tell your healthcare provider if you:

What are the serious side effects of Remodulin?

What are the possible side effects of Remodulin?

You may report side effects to the FDA at www.fda.gov/MedWatch or call 1-800-FDA-1088.

The risk information provided here is not comprehensive.

What is Remodulin?

Remodulin is a prescription medication used to treat adults with pulmonary arterial hypertension (PAH; WHO Group 1), which is high blood pressure in the arteries of your lungs. Remodulin can reduce symptoms associated with exercise. Remodulin was studied mainly in patients with NYHA Functional Class II-IV symptoms. It is not known if Remodulin is safe and effective in children.

In people with PAH who need to switch from epoprostenol, Remodulin is approved to slow the worsening of symptoms.

REMISIconOct19

To learn more about Remodulin, talk with your healthcare provider. Please see Full Prescribing Information at www.remodulin.com or call Customer Service at 1-877-UNITHER (1-877-864-8437).

PAH=pulmonary arterial hypertension; WHO=World Health Organization.